GLMD icon

Galmed Pharmaceuticals

18 hedge funds and large institutions have $3.56M invested in Galmed Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$1.3M 264,600
PWAM
2
Park West Asset Management
California
$1.01M 205,500
PA
3
Perceptive Advisors
New York
$369K 75,000
KCM
4
Knoll Capital Management
Florida
$320K 65,000
SKK
5
Shepherd Kaplan Krochuk
Massachusetts
$158K 31,990 +13,300 +71%
MC
6
Menta Capital
California
$86K 17,348 +400 +2%
DCM
7
DAFNA Capital Management
California
$66K 13,488 +1,500 +13%
CA
8
CapWealth Advisors
Tennessee
$59K 12,000
Goldman Sachs
9
Goldman Sachs
New York
$58K 11,831 -3,221 -21%
CAD
10
Craig A. Drill
$49K 10,000 +10,000 New
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$26K 5,176
Morgan Stanley
12
Morgan Stanley
New York
$24K 4,851 -1,500 -24%
Barclays
13
Barclays
United Kingdom
$10K 2,380 +2,380 New
EDRH
14
Edmond de Rothschild Holding
Switzerland
$5K 916
EDRE
15
Edmond de Rothschild (Europe)
Luxembourg
$5K 916
UBS Group
16
UBS Group
Switzerland
$3K 602 -4,017 -87%
Bank of America
17
Bank of America
North Carolina
$2K 460 -38 -8%
RFA
18
Reilly Financial Advisors
California
$1K 250 +250 New
Vanguard Group
19
Vanguard Group
Pennsylvania
-31,794 Closed
Geode Capital Management
20
Geode Capital Management
Massachusetts
-29,374 Closed
BIT
21
BlackRock Institutional Trust
California
-11,602 Closed
BA
22
BlackRock Advisors
Delaware
-2,061 Closed
BFA
23
BlackRock Fund Advisors
California
-876 Closed